發(fā)布時(shí)間：2018-08-04 08:53

【摘要】：目的:本研究旨在客觀評(píng)價(jià)針刺聯(lián)合常規(guī)療法治療前部缺血性視神經(jīng)病變(AION)的療效。材料與方法:將符合納入標(biāo)準(zhǔn)的60例前部缺血性視神經(jīng)病變患者,隨機(jī)分為實(shí)驗(yàn)組和對(duì)照組,對(duì)于實(shí)驗(yàn)組患者采用針刺聯(lián)合常規(guī)治療,針刺穴位:睛明、太陽(yáng)、百會(huì)、合谷、足三里;針對(duì)對(duì)照組患者則單純應(yīng)用常規(guī)治療:局部應(yīng)用糖皮質(zhì)激素,靜脈滴注及皮下注射改善循環(huán)擴(kuò)血管、營(yíng)養(yǎng)神經(jīng)藥,口服B族維生素,應(yīng)用降眼壓眼水點(diǎn)眼,治療15天后觀察兩組治療前后患者的最佳矯正視力、視野的提高程度,評(píng)價(jià)臨床療效。結(jié)果:實(shí)驗(yàn)組和對(duì)照組的視野平均缺損(MD)和最佳矯正視力在治療后與治療前相比,均具有統(tǒng)計(jì)學(xué)差異,P0.05;視野MD和最佳矯正視力分別在治療后進(jìn)行兩組間對(duì)比,均具有統(tǒng)計(jì)學(xué)差異,P0.05;兩組間視野MD、最佳矯正視力在治療前后的差值對(duì)比,經(jīng)統(tǒng)計(jì)學(xué)分析,均具有顯著差異,P0.01,說(shuō)明經(jīng)治療后針刺聯(lián)合常規(guī)治療組在視野平均缺損和最佳矯正視力的的改善均優(yōu)于常規(guī)治療組;針刺聯(lián)合常規(guī)治療組中患者治愈6例,顯效14例,有效11例,無(wú)效3例,總有效率91.17%,常規(guī)治療組中治愈2例,顯效7例,有效19例,無(wú)效6例,總有效率82.35%,經(jīng)秩和檢驗(yàn),Z=2.594,P=0.009(P0.05),兩組療效差異有統(tǒng)計(jì)學(xué)意義,針刺聯(lián)合常規(guī)治療組療效優(yōu)于常規(guī)治療組。結(jié)論:針刺聯(lián)合常規(guī)療法治療前部缺血性視神經(jīng)病變的臨床療效較單純應(yīng)用常規(guī)治療要好,在常規(guī)治療的基礎(chǔ)上加以針刺,能夠更好的提升患者的最佳矯正視力,減輕視野平均缺損,促進(jìn)患者視神經(jīng)的恢復(fù)。
[Abstract]:Objective: to evaluate the efficacy of acupuncture combined with conventional therapy in the treatment of anterior ischemic optic neuropathy (AION). Materials and methods: sixty patients with anterior ischemic optic neuropathy were randomly divided into experimental group and control group. Zusanli; for the patients in the control group, only routine treatment was used: local administration of glucocorticoid, intravenous drip and subcutaneous injection to improve circulation and vasodilator, nutrition and neurodrugs, oral administration of group B vitamins, and eye drops of ocular pressure relief. After 15 days of treatment, the best corrected visual acuity and visual field were observed before and after treatment, and the clinical efficacy was evaluated. Results: the mean visual field defect (MD) and best corrected visual acuity (BCVA) in the experimental group and the control group were significantly different from those before treatment (P 0.05), the visual field MD and the best corrected visual acuity (BCVA) were compared between the two groups after treatment. There was statistical difference between the two groups (P 0.05). The difference between the two groups of MDS and BCVA before and after treatment was compared by statistical analysis. There were significant differences between the two groups (P 0.01), which indicated that the improvement of mean visual field defect and best corrected visual acuity in the acupuncture combined with routine treatment group was better than that in the conventional treatment group, and 6 cases were cured, 14 cases were effective and 11 cases were effective in the acupuncture combined with routine treatment group. In the routine treatment group, 2 cases were cured, 7 cases were markedly effective, 19 cases were effective, 6 cases were ineffective, and the total effective rate was 82.35%. The difference between the two groups was statistically significant (P0.05). The curative effect of acupuncture combined with routine treatment group was better than that of routine treatment group. Conclusion: the clinical effect of acupuncture combined with conventional therapy for anterior ischemic optic neuropathy is better than that of simple routine treatment. Acupuncture on the basis of routine treatment can better improve the best corrected visual acuity of patients. To reduce the mean defect of visual field and promote the recovery of optic nerve.
【學(xué)位授予單位】：遼寧中醫(yī)藥大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R774.6

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 趙仲平;郭翠玲;邵鴻展;任韓;何瓊敏;;神經(jīng)生長(zhǎng)因子多藥聯(lián)合治療缺血性視神經(jīng)病變患者的臨床療效[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2015年20期

2 楊平;;前部缺血性視神經(jīng)病變的危險(xiǎn)因素及治療分析[J];中國(guó)現(xiàn)代藥物應(yīng)用;2015年06期

3 廖良;韋企平;;韋企平治療非動(dòng)脈炎性前部缺血性視神經(jīng)病變臨證經(jīng)驗(yàn)[J];中國(guó)中醫(yī)眼科雜志;2014年05期

4 魯誠(chéng);;中西醫(yī)結(jié)合治療前部缺血性視神經(jīng)病變治療的臨床研究[J];中國(guó)醫(yī)藥指南;2014年20期

5 陸勤康;張軍濤;趙娜;王惠云;童奇湖;王守麗;;中西藥聯(lián)合治療前部缺血性視神經(jīng)病變的臨床研究[J];中華中醫(yī)藥學(xué)刊;2014年06期

6 海英;田維柱;;眼針針刺手法探析[J];中國(guó)針灸;2013年09期

7 侯雅慧;;針灸聯(lián)合中藥治療缺血性視神經(jīng)病變療效觀察[J];中外醫(yī)療;2013年22期

8 張國(guó)亮;吳烈;康瑋;;中西醫(yī)結(jié)合治療前部缺血性視神經(jīng)病變的臨床觀察[J];中國(guó)中醫(yī)眼科雜志;2013年03期

9 唐苗苗;沈蘭珂;唐浩;王滿華;;針刺結(jié)合補(bǔ)氣活血法治療前部缺血性視神經(jīng)病變療效觀察[J];中國(guó)中醫(yī)眼科雜志;2013年02期

10 宋哲;丁波;沈瓊;井文貴;;高壓氧治療不良反應(yīng)及并發(fā)癥的預(yù)防與處理[J];臨床誤診誤治;2012年05期

相關(guān)博士學(xué)位論文 前1條

1 楊薇;高健生學(xué)術(shù)思想及益氣升陽(yáng)舉陷法治療眼科疾病臨床經(jīng)驗(yàn)整理研究[D];中國(guó)中醫(yī)科學(xué)院;2012年

相關(guān)碩士學(xué)位論文 前2條

1 張蒙恩;多功能樹狀大分子納米載藥體系的構(gòu)建及其腫瘤治療應(yīng)用[D];東華大學(xué);2013年

2 趙云;眼玻璃體內(nèi)和球后注射曲安奈德治療非動(dòng)脈炎性前部缺血性視神經(jīng)病變的臨床研究[D];河北醫(yī)科大學(xué);2012年

，

本文編號(hào)：2163288